FDA AdComm Will Address Breast Implant Risks, Benefits At March Meeting

US FDA’s General and Plastic Surgery Devices advisory panel will meet for two days in March to explore the risks and benefits of both silicone gel-filled and saline-filled breast implants.

Silicone breast implant
US FDA will explore breast implant risks and benefits at a March meeting.

More from Regulation

More from Policy & Regulation